VALENSIN, PIER EGISTO
 Distribuzione geografica
Continente #
NA - Nord America 4.975
EU - Europa 3.253
AS - Asia 2.034
SA - Sud America 326
AF - Africa 113
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.708
Nazione #
US - Stati Uniti d'America 4.937
CN - Cina 809
RU - Federazione Russa 695
GB - Regno Unito 618
SG - Singapore 575
IE - Irlanda 518
UA - Ucraina 338
SE - Svezia 296
BR - Brasile 274
DE - Germania 242
FR - Francia 239
VN - Vietnam 192
HK - Hong Kong 162
FI - Finlandia 124
KR - Corea 111
IT - Italia 75
ZA - Sudafrica 64
IN - India 48
ES - Italia 31
BD - Bangladesh 20
NG - Nigeria 19
JP - Giappone 17
MX - Messico 17
PL - Polonia 15
AR - Argentina 14
IQ - Iraq 14
CA - Canada 13
NL - Olanda 12
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
EC - Ecuador 10
TR - Turchia 10
ID - Indonesia 8
BE - Belgio 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
JO - Giordania 6
SA - Arabia Saudita 6
VE - Venezuela 6
AU - Australia 5
CI - Costa d'Avorio 5
KG - Kirghizistan 5
LB - Libano 5
LT - Lituania 5
PK - Pakistan 5
CL - Cile 4
HU - Ungheria 4
LU - Lussemburgo 4
PE - Perù 4
PH - Filippine 4
RS - Serbia 4
BO - Bolivia 3
DZ - Algeria 3
IR - Iran 3
MY - Malesia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UY - Uruguay 3
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NP - Nepal 2
PY - Paraguay 2
SC - Seychelles 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
SD - Sudan 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 10.708
Città #
Dallas 563
Southend 522
Fairfield 517
Dublin 512
Ashburn 394
Singapore 318
Chandler 309
Jacksonville 265
Woodbridge 247
Santa Clara 236
Menlo Park 235
Moscow 198
Houston 185
Wilmington 179
Seattle 178
Cambridge 176
Beijing 167
Hong Kong 152
Ann Arbor 143
San Jose 132
Hefei 110
Seoul 110
Princeton 91
Nanjing 90
The Dalles 83
New York 76
Ho Chi Minh City 66
Johannesburg 60
Los Angeles 57
Helsinki 54
Munich 54
Hanoi 53
Lauterbourg 47
Shanghai 40
Boardman 39
Nanchang 33
San Diego 29
Buffalo 25
London 21
São Paulo 21
San Mateo 20
Columbus 19
Abuja 18
Frankfurt am Main 18
Hebei 17
Málaga 17
Siena 17
Turku 17
Council Bluffs 16
Lancaster 16
Redondo Beach 16
Venezia 16
Jiaxing 15
Orem 15
Changsha 14
Shenyang 14
Tianjin 14
San Francisco 11
Tokyo 11
Warsaw 11
Washington 11
Brooklyn 10
Dearborn 10
Haiphong 10
Bengaluru 9
Chennai 9
Kunming 9
Norwalk 9
Chicago 8
Da Nang 8
Denver 8
Guangzhou 8
Redwood City 8
Tashkent 8
Hangzhou 7
Jinan 7
Phoenix 7
Renton 7
Zhengzhou 7
Amman 6
Belo Horizonte 6
Boston 6
Brno 6
Brussels 6
Düsseldorf 6
Guarulhos 6
Porto Alegre 6
Rio de Janeiro 6
Toronto 6
Abidjan 5
Bishkek 5
Changchun 5
Dubai 5
Fremont 5
Lanzhou 5
Madrid 5
Mexico City 5
Mumbai 5
Ankara 4
Brasília 4
Totale 7.372
Nome #
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 364
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 312
Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type 1 nucleoside reverse transcriptase inhibitors 271
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples 266
Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy. 255
Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine and protease inhibitors 250
Analysis of the HIV-1 nef gene in five intravenous drug users with long-term nonprogressive HIV-1 infection in Italy. 249
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 244
Helicobacter pylori infection and infertility 235
Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8 coinfected patients 234
Concordance between polymerase chain reaction and antibody detection in the diagnosis of human immunodeficiency virus type 1 infection. 232
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 230
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 226
Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice. 224
Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. 222
Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy 221
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 217
Long-read direct infrared sequencing of crude PCR products for prediction of resistance to HIV-1 reverse transcriptase and protease inhibitors. 217
Hepatitis C virus infection and myositis: a polymerase chain reaction study 216
Microfilament and microtubule alterations in cultured CHO cells during methyl mercury intoxication and protection with selenite 214
The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C 213
Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy 200
Evaluation of cell-free and cell-associated peripheral blood HIV-1 RNA response to antiretroviral therapy 199
Synthetic peptides of rubella E1 glycoprotein for serological assays 198
Clinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 plasma RNA. 196
Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: longitudinal evaluation of six patients under treatment 190
Nested polymerase chain reaction for detection of human immunodeficiency virus type 1 DNA in clinical specimens. 183
Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype 183
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 178
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 177
Optimal conditions for detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction with nested primers 177
Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from human immunodeficiency virus type 1 genotype 176
Live-cell immunofluorescence for detection of human immunodeficiency virus type 1 (HIV-1)-related antigens in peripheral blood mononuclear cells from HIV-1-seropositive individuals 175
NMR investigation of cell cultures: early detection of infection by Herpes simplex virus type 2 and transformation 174
Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice 174
Binding properties of monoclonal antibodies to rabies virus 172
Low human immunodeficiency virus titer and polymerase chain reaction false-negatives 170
Human immunodeficiency virus-1 infection, homosexuality, and Kaposi-associated herpes-like DNA in peripheral blood mononuclear cells 170
Comparison of M-MLV reverse transcriptase and Tth polymerase activity in RT-PCR of samples with low virus burden 167
Identification of Mycobacterium tuberculosis complex, Mycobacterium avium and Mycobacterium intracellulare by selective nested polymerase chain reaction 165
Increased reliability of 'selective PCR' using additionally mutated primers and a commercial 'Taq DNA polymerase enhancer' 161
Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine 160
Expression of measles virus antigens in Streptococcus gordonii 154
Evaluation of the specific immune response after anti-rubella vaccination [Valutazione della risposta immunitaria specifica dopo vaccinazione anti-rosolia] 153
Lack of efficacy of ozone therapy in HIV infection 151
Expression of recombinant E2 and C proteins of rubella virus in insect cells 146
Rapid detection and typing of circulating mumps virus by reverse transcription/polymerase chain reaction 145
Low human immunodeficiency virus type 1 (HIV-1)DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimens by PCR 143
Streptococcus gordonii as a live vaccine vector [Lo Streptococcus gordonii come vettore di vaccini ricombinanti] 143
Ultrasensitive in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma 140
Serological evidence of reinfection among vaccinees during rubella outbreak 138
Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis 138
Simultaneous amplification of multiple human immunodeficiency virus type 1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction 134
Viral childhood gastroenteritis 129
Rubella epidemiology over a 14-year period in Siena (Italy): a retrospective serological survey 121
Polymerase chain reaction for detection of human immunodeficiency virus type 1 DNA in peripheral lymphocytes. Results in subjects with high risk of HIV infection 41
Totale 10.733
Categoria #
all - tutte 32.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022579 36 78 22 46 51 9 35 19 30 77 43 133
2022/20231.064 61 94 146 159 97 226 8 97 88 26 35 27
2023/2024778 21 19 92 46 26 262 256 15 3 4 1 33
2024/20251.400 34 73 124 57 193 85 21 74 124 46 152 417
2025/20263.237 279 461 498 345 645 120 379 142 103 167 53 45
Totale 10.733